10x Genomics, Inc.
TXG
$9.42
$0.313.40%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 29.92% | -37.13% | 5.66% | 36.78% | -22.46% |
| Total Depreciation and Amortization | -7.10% | -1.73% | -1.38% | -5.17% | -1.81% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -7.49% | -1.66% | -12.72% | -1.20% | -15.04% |
| Change in Net Operating Assets | 2,155.23% | -110.59% | 419.61% | 35.45% | -136.90% |
| Cash from Operations | 609.05% | -131.18% | 188.70% | 147.67% | -161.05% |
| Capital Expenditure | 30.30% | 30.16% | -35.13% | 1.10% | 15.65% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -18,135.42% | -98.17% | 9.47% | -18.17% |
| Cash from Investing | 96.33% | -1,325.98% | -130.28% | 12.37% | -18.83% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -90.66% | 2,795.51% | -96.61% | 181.01% | -70.82% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -90.66% | 2,795.51% | -96.61% | 181.01% | -70.82% |
| Foreign Exchange rate Adjustments | 142.38% | -272.44% | 5,300.00% | 93.75% | -162.34% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 161.00% | -395.02% | -23.74% | 786.35% | -107.86% |